Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (311-320 of 645) with videos related to

Pageof 65
Sort By:
Immunotherapy|October 2, 2023
What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trialsMario Cazzola, Clive Page, Luigino Calzetta, et al.
Pulmonary Pharmacology & Therapeutics|June 30, 2006
Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combinationRachel A Brown, Luigi Allegra, Maria G Matera, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 11, 2018
N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbationLuigino Calzetta, Paola Rogliani, Francesco Facciolo, et al.
Pulmonary Pharmacology & Therapeutics|October 13, 2004
Potential genetic influences on the response to asthma treatmentGirolamo Pelaia, Alessandro Vatrella, Luca Gallelli, et al.
COPD|September 16, 2014
Translational Study Searching for Synergy between Glycopyrronium and IndacaterolMario Cazzola, Luigino Calzetta, Andrea Segreti, et al.
Respiratory Medicine|August 26, 2015
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedsideMario Cazzola, Luigino Calzetta, Josuel Ora, et al.
European Journal of Pharmacology|July 19, 2017
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchiLuigino Calzetta, Paola Rogliani, Francesco Facciolo, et al.
Trends in Pharmacological Sciences|August 9, 2017
Targeting Mechanisms Linking COPD to Type 2 Diabetes MellitusMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Respiratory Medicine|April 22, 2006
Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot studyFabiano Di Marco, Massimo Verga, Pierachille Santus, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2015
A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challengesMario Cazzola, Nicola Alexander Hanania, William MacNee, et al.
Pageof 65

Showing results (311-320 of 645) with videos related to

Sort By:
Pageof 65
Immunotherapy|October 2, 2023
What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trialsMario Cazzola, Clive Page, Luigino Calzetta, et al.
Pulmonary Pharmacology & Therapeutics|June 30, 2006
Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combinationRachel A Brown, Luigi Allegra, Maria G Matera, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 11, 2018
N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbationLuigino Calzetta, Paola Rogliani, Francesco Facciolo, et al.
Pulmonary Pharmacology & Therapeutics|October 13, 2004
Potential genetic influences on the response to asthma treatmentGirolamo Pelaia, Alessandro Vatrella, Luca Gallelli, et al.
COPD|September 16, 2014
Translational Study Searching for Synergy between Glycopyrronium and IndacaterolMario Cazzola, Luigino Calzetta, Andrea Segreti, et al.
Respiratory Medicine|August 26, 2015
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedsideMario Cazzola, Luigino Calzetta, Josuel Ora, et al.
European Journal of Pharmacology|July 19, 2017
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchiLuigino Calzetta, Paola Rogliani, Francesco Facciolo, et al.
Trends in Pharmacological Sciences|August 9, 2017
Targeting Mechanisms Linking COPD to Type 2 Diabetes MellitusMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Respiratory Medicine|April 22, 2006
Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot studyFabiano Di Marco, Massimo Verga, Pierachille Santus, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2015
A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challengesMario Cazzola, Nicola Alexander Hanania, William MacNee, et al.
Pageof 65